)
Surrozen (SRZN) investor relations material
Surrozen Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for May 13, 2026, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials and vote by May 12, 2026.
Voting matters and shareholder proposals
Election of two Class II directors to serve until the 2029 annual meeting.
Ratification of Ernst & Young LLP as independent auditor for the year ending December 31, 2026.
Advisory approval of executive compensation for named executive officers.
Advisory vote on the preferred frequency of future say-on-pay votes.
Board of directors and corporate governance
Nominees for Class II director positions are Mace Rothenberg, M.D., and David J. Woodhouse, Ph.D.
- Annual meeting covers director elections, auditor ratification, and executive compensation votes.SRZN
Proxy filing1 Apr 2026 - Multi-functional antibodies targeting Wnt, VEGF, and IL-6 address major unmet needs in retinal disease.SRZN
Corporate presentation24 Mar 2026 - Biotech firm launches $200M shelf, including $50M ATM with TD Cowen, targeting ophthalmology.SRZN
Registration filing23 Mar 2026 - Cash rose to $89M, net loss widened to $242M, IND for SZN-8141 expected H2 2026.SRZN
Q4 202523 Mar 2026 - Advancing multispecific antibody therapies for retinal diseases, aiming for superior outcomes.SRZN
TD Cowen 46th Annual Health Care Conference4 Mar 2026 - Lead Wnt/VEGF bispecifics advance toward IND in 2026, backed by strong IP and financials.SRZN
Guggenheim Securities Emerging Outlook: Biotech Summit 202612 Feb 2026 - Bispecific antibodies targeting Wnt signaling may transform retinal disease treatment by 2026.SRZN
H.C. Wainwright 27th Annual Global Investment Conference3 Feb 2026 - Tissue-targeted Wnt therapies show promise in liver and eye diseases, with pivotal data ahead.SRZN
Guggenheim Securities Inaugural Healthcare Innovation Conference14 Jan 2026 - Lead SAH therapy shows early safety, with key data and financial milestones expected in 2025.SRZN
Stifel 2024 Healthcare Conference13 Jan 2026
Next Surrozen earnings date
Next Surrozen earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage